美国普通医疗环境中慢性乙型肝炎患者的临床评估不频繁。
Infrequent Clinical Assessment of Chronic Hepatitis B Patients in United States General Healthcare Settings.
作者信息
Spradling Philip R, Xing Jian, Rupp Loralee B, Moorman Anne C, Gordon Stuart C, Teshale Eyasu T, Lu Mei, Boscarino Joseph A, Trinacty Connie M, Schmidt Mark A, Holmberg Scott D
机构信息
Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia.
出版信息
Clin Infect Dis. 2016 Nov 1;63(9):1205-1208. doi: 10.1093/cid/ciw516. Epub 2016 Aug 2.
Abstract
Among 2338 chronic hepatitis B patients followed during 2006-2013 in the Chronic Hepatitis Cohort Study, 78% had ≥1 alanine aminotransferase and 37% had ≥1 hepatitis B virus DNA level assessed annually. Among cirrhotic patients, 46% never had hepatic imaging. Patients in this cohort were insufficiently monitored for disease activity and hepatocellular carcinoma.
摘要
在2006年至2013年慢性丙型肝炎队列研究中随访的2338例慢性乙型肝炎患者中，78%的患者每年至少有1次丙氨酸转氨酶升高，37%的患者每年至少有1次乙肝病毒DNA水平检测。在肝硬化患者中，46%从未进行过肝脏影像学检查。该队列中的患者对疾病活动和肝细胞癌的监测不足。
相似文献
1
Infrequent Clinical Assessment of Chronic Hepatitis B Patients in United States General Healthcare Settings.美国普通医疗环境中慢性乙型肝炎患者的临床评估不频繁。
Clin Infect Dis. 2016 Nov 1;63(9):1205-1208. doi: 10.1093/cid/ciw516. Epub 2016 Aug 2.
2
Retrospective analysis of hepatitis B virus chronic infection in 247 patients: clinical stages, response to treatment and poor prognostic factors.247例慢性乙型肝炎病毒感染患者的回顾性分析：临床分期、治疗反应及不良预后因素
Braz J Infect Dis. 2017 Jul-Aug;21(4):441-447. doi: 10.1016/j.bjid.2017.03.019. Epub 2017 May 26.
3
Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population.美国人群中慢性乙型肝炎病毒感染的抗病毒治疗与肝细胞癌的发生
Clin Gastroenterol Hepatol. 2014 May;12(5):885-93. doi: 10.1016/j.cgh.2013.09.062. Epub 2013 Oct 6.
4
Clinical outcomes of lamivudine-adefovir therapy in chronic hepatitis B cirrhosis.拉米夫定-阿德福韦酯治疗慢性乙型肝炎肝硬化的临床结局。
J Clin Gastroenterol. 2011 Oct;45(9):818-23. doi: 10.1097/MCG.0b013e318214ab5d.
5
Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.长期使用富马酸替诺福韦二吡呋酯对慢性乙型肝炎患者肝细胞癌发生率的影响。
Cancer. 2015 Oct 15;121(20):3631-8. doi: 10.1002/cncr.29537. Epub 2015 Jul 15.
6
Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis.恩替卡韦治疗可减少肝硬化慢性乙型肝炎患者的肝脏事件和死亡。
Hepatology. 2013 Nov;58(5):1537-47. doi: 10.1002/hep.26301. Epub 2013 Sep 30.
7
Clinical outcomes of untreated adults living with chronic hepatitis B in The Gambia: an analysis of data from the prospective PROLIFICA cohort study.冈比亚未经治疗的慢性乙型肝炎成人患者的临床结局：对前瞻性 PROLIFICA 队列研究数据的分析。
Lancet Gastroenterol Hepatol. 2024 Dec;9(12):1133-1146. doi: 10.1016/S2468-1253(24)00226-7.
8
Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status.肝硬化而非抗病毒治疗可预测具有不同乙型肝炎病毒状态的队列的临床结局。
Gut Liver. 2019 Mar 15;13(2):197-205. doi: 10.5009/gnl18204.
9
Baseline Hepatitis B Virus DNA Level is a Promising Factor for Predicting the 3 (rd) Month Virological Response to Entecavir Therapy: A Study of Strict Defined Hepatitis B virus Induced Cirrhosis.基线乙型肝炎病毒DNA水平是预测恩替卡韦治疗3个月病毒学应答的一个有前景的因素：一项关于严格定义的乙型肝炎病毒所致肝硬化的研究
Chin Med J (Engl). 2015 Jul 20;128(14):1867-72. doi: 10.4103/0366-6999.160488.
10
Monitoring the effect of antiviral treatment on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis B patients.监测抗病毒治疗对慢性乙型肝炎患者肝硬化和肝细胞癌发生发展的影响。
Rev Assoc Med Bras (1992). 2024 Dec 2;70(12):e20240803. doi: 10.1590/1806-9282.20240803. eCollection 2024.
引用本文的文献
1
Cost-effectiveness of monitoring and liver cancer surveillance among patients with inactive chronic hepatitis B.慢性乙型肝炎非活动期患者监测及肝癌筛查的成本效益分析
PLoS One. 2025 Jan 22;20(1):e0313898. doi: 10.1371/journal.pone.0313898. eCollection 2025.
2
It Is Time for a Simplified Approach to Hepatitis B Elimination.是时候采取简化方法消除乙型肝炎了。
Gastro Hep Adv. 2022 Oct 14;2(2):209-218. doi: 10.1016/j.gastha.2022.10.004. eCollection 2023.
3
The Impact of Living With Chronic Hepatitis B on Quality of Life: Implications for Clinical Management.慢性乙型肝炎患者的生活对生活质量的影响：对临床管理的启示。
J Patient Exp. 2023 Nov 13;10:23743735231211069. doi: 10.1177/23743735231211069. eCollection 2023.
4
Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three Continents: Retrospective Cross-Sectional Cohort Studies.三大洲慢性乙型肝炎病毒感染患者的生化指标与治疗需求：回顾性横断面队列研究
Infect Dis Ther. 2023 Nov;12(11):2513-2532. doi: 10.1007/s40121-023-00824-y. Epub 2023 Jul 11.
5
Leveraging a community-based participatory approach to improve linkage to care for HBV.利用基于社区的参与式方法来改善乙肝护理的联系。
Clin Liver Dis (Hoboken). 2023 Apr 18;21(4):117-121. doi: 10.1097/CLD.0000000000000032. eCollection 2023 Apr.
6
Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations - United States, 2023.乙型肝炎病毒感染的筛查和检测：美国疾病预防控制中心推荐 - 2023 年。
MMWR Recomm Rep. 2023 Mar 10;72(1):1-25. doi: 10.15585/mmwr.rr7201a1.
7
Baseline assessment of and linkage to care for newly diagnosed patients with chronic hepatitis B.新诊断慢性乙型肝炎患者的基线评估及护理衔接
Can Liver J. 2020 Aug 20;3(3):263-275. doi: 10.3138/canlivj.2019-0024. eCollection 2020 Summer.
8
Health Insurance Status of Adults with Hepatitis in the United States: Implications of Results from the National Health Interview Survey, 2013-2018.美国成人肝炎患者的健康保险状况：2013 - 2018年国家健康访谈调查结果的启示
Popul Health Manag. 2021 Dec;24(6):651-653. doi: 10.1089/pop.2021.0053. Epub 2021 Apr 27.
9
TREAT-B: Simple Low-Cost Diagnostic Score for When to Treat Hepatitis B.TREAT-B：何时治疗乙型肝炎的简单低成本诊断评分
Clin Infect Dis. 2021 Sep 7;73(5):e1078-e1079. doi: 10.1093/cid/ciaa1820.
10
Surveillance-Based Estimate of the Prevalence of Chronic Hepatitis B Virus Infection, New York City, 2016.基于监测的 2016 年纽约市慢性乙型肝炎病毒感染患病率估计。
Public Health Rep. 2019 Nov/Dec;134(6):695-702. doi: 10.1177/0033354919882962. Epub 2019 Oct 24.
本文引用的文献
1
AASLD guidelines for treatment of chronic hepatitis B.美国肝病研究学会慢性乙型肝炎治疗指南。
Hepatology. 2016 Jan;63(1):261-83. doi: 10.1002/hep.28156. Epub 2015 Nov 13.
2
Care delivery and outcomes among US veterans with hepatitis B: A national cohort study.美国乙型肝炎患者的护理提供和结果：一项全国队列研究。
Hepatology. 2016 Jun;63(6):1774-82. doi: 10.1002/hep.28340. Epub 2016 Feb 25.
3
Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988-2012.美国居民慢性乙型肝炎病毒（HBV）感染率：1988-2012 年全国健康和营养调查（NHANES）。
Hepatology. 2016 Feb;63(2):388-97. doi: 10.1002/hep.28109. Epub 2015 Oct 27.
4
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update.《亚太地区慢性乙型肝炎管理共识声明：2012年更新版》
Hepatol Int. 2012 Jun;6(3):531-61. doi: 10.1007/s12072-012-9365-4. Epub 2012 May 17.
5
Poor adherence to AASLD guidelines for chronic hepatitis B Management and treatment in a large academic medical center.在大型学术医疗中心，慢性乙型肝炎管理和治疗中对 AASLD 指南的依从性较差。
Am J Gastroenterol. 2014 Jun;109(6):867-75. doi: 10.1038/ajg.2014.72. Epub 2014 Apr 15.
6
The validity of serum markers for fibrosis staging in chronic hepatitis B and C.慢性乙型和丙型肝炎中纤维化分期血清标志物的有效性。
J Viral Hepat. 2014 Dec;21(12):930-7. doi: 10.1111/jvh.12224. Epub 2014 Jan 29.
7
Management of hepatitis B: our practice and how it relates to the guidelines.乙型肝炎管理：我们的实践及其与指南的关系。
Clin Gastroenterol Hepatol. 2014 Jan;12(1):16-26. doi: 10.1016/j.cgh.2013.04.036. Epub 2013 May 6.
8
Baseline characteristics and mortality among people in care for chronic viral hepatitis: the chronic hepatitis cohort study.接受慢性病毒性肝炎治疗人群的基线特征和死亡率：慢性肝炎队列研究。
Clin Infect Dis. 2013 Jan;56(1):40-50. doi: 10.1093/cid/cis815. Epub 2012 Sep 18.
9
EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.欧洲肝脏研究学会临床实践指南：慢性乙型肝炎病毒感染的管理
J Hepatol. 2012 Jul;57(1):167-85. doi: 10.1016/j.jhep.2012.02.010. Epub 2012 Mar 20.
10
Is chronic hepatitis B being undertreated in the United States?美国是否存在慢性乙型肝炎治疗不足的情况？
J Viral Hepat. 2011 Jun;18(6):377-83. doi: 10.1111/j.1365-2893.2010.01401.x. Epub 2010 Dec 8.
Zotero 插件